Contents

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued), Volume 1 - Number 1

Foreword from the Editor

, 1(1): 1

Sun Ying


DOI: 10.2174/2212703801999140226095618




Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

, 1(1): 2 - 10

Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen


DOI: 10.2174/2212703801999131206110837




Cells and Mediators of Inflammation in Acute Pancreatitis

, 1(1): 11 - 23

Ramesh Kumar and Madhav Bhatia


DOI: 10.2174/2212703801999131206110914




Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

, 1(1): 24 - 31

Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu


DOI: 10.2174/22127038114019990003




In Vitro Analysis of Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis as a Possible Predictable Marker of TNF-alpha Blockers

, 1(1): 32 - 38

Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada


DOI: 10.2174/22127038114016660004




Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents

, 1(1): 39 - 44

Mayura A. Kale, Ashok S. Narute and Tukaram M. Kalyankar


DOI: 10.2174/2212703801666131209232632




Activin-A: A New Piece in the Puzzle of Tolerance in Asthma

, 1(1): 45 - 56

Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou


DOI: 10.2174/2212703801666140221004020




Hydrogen Sulfide: A New Tool to Design and Develop Drugs

, 1(1): 57 - 66

Nethaji Muniraj, Abel Damien Ang, Alireza Badiei, Jack Rivers-Auty and Madhav Bhatia


DOI: 10.2174/2212703801666140311005131




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science